Effect of CYP3A-inducing anti-epileptics on sorafenib exposure: results of a phase II study of sorafenib plus daily temozolomide in adults ... View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2011-01

AUTHORS

David A. Reardon, James J. Vredenburgh, Annick Desjardins, Katherine Peters, Sridharan Gururangan, John H. Sampson, Jennifer Marcello, James E. Herndon, Roger E. McLendon, Dorothea Janney, Allan H. Friedman, Darell D. Bigner, Henry S. Friedman

ABSTRACT

Sorafenib, an oral VEGFR-2, Raf, PDGFR, c-KIT and Flt-3 inhibitor, is active against renal cell and hepatocellular carcinomas, and has recently demonstrated promising activity for lung and breast cancers. In addition, various protracted temozolomide dosing schedules have been evaluated as a strategy to further enhance its anti-tumor activity. We reasoned that sorafenib and protracted, daily temozolomide may provide complementary therapeutic benefit, and therefore performed a phase 2 trial among recurrent glioblastoma patients. Adult glioblastoma patients at any recurrence after standard temozolomide chemoradiotherapy received sorafenib (400 mg twice daily) and continuous daily temozolomide (50 mg/m²/day). Assessments were performed every eight weeks. The primary endpoint was progression-free survival at 6 months (PFS-6) and secondary end points were radiographic response, overall survival (OS), safety and sorafenib pharmacokinetics. Of 32 enrolled patients, 12 (38%) were on CYP3-A inducing anti-epileptics (EIAEDs), 17 (53%) had 2 or more prior progressions, 15 had progressed while receiving 5-day temozolomide, and 12 (38%) had failed either prior bevacizumab or VEGFR inhibitor therapy. The most common grade ≥ 3 toxicities were palmer-planter erythrodysesthesia (19%) and elevated amylase/lipase (13%). Sorafenib pharmacokinetic exposures were comparable on day 1 regardless of EIAED status, but significantly lower on day 28 for patients on EIAEDs (P = 0.0431). With a median follow-up of 93 weeks, PFS-6 was 9.4%. Only one patient (3%) achieved a partial response. In conclusion, sorafenib can be safely administered with daily temozolomide, but this regimen has limited activity for recurrent GBM. Co-administration of EIAEDs can lower sorafenib exposures in this population. More... »

PAGES

57-66

References to SciGraph publications

  • 2006-05. Lack of effect of ketoconazole-mediated CYP3A inhibition on sorafenib clinical pharmacokinetics in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2006-11. Temozolomide 3 weeks on and 1 week off as first-line therapy for recurrent glioblastoma: phase II study from gruppo italiano cooperativo di neuro-oncologia (GICNO) in BRITISH JOURNAL OF CANCER
  • 2005-05. Phase I safety and pharmacokinetics of BAY 43-9006 administered for 21 days on/7 days off in patients with advanced, refractory solid tumours in BRITISH JOURNAL OF CANCER
  • 2009-04. Phase II trial of two different irinotecan schedules with pharmacokinetic analysis in patients with recurrent glioma: North Central Cancer Treatment Group results in JOURNAL OF NEURO-ONCOLOGY
  • 2002-06. Mutations of the BRAF gene in human cancer in NATURE
  • 2009-01. Sorafenib in DRUGS
  • 2004-10. Phase II Study of Concurrent Continuous Temozolomide (TMZ) and Tamoxifen (TMX) for Recurrent Malignant Astrocytic Gliomas in JOURNAL OF NEURO-ONCOLOGY
  • 2009-09. Expression, mutation and copy number analysis of platelet-derived growth factor receptor A (PDGFRA) and its ligand PDGFA in gliomas in BRITISH JOURNAL OF CANCER
  • 2010-02. Extended-schedule dose-dense temozolomide in refractory gliomas in JOURNAL OF NEURO-ONCOLOGY
  • 2003-04. Marked inactivation of <i>O</i><sup>6</sup>-alkylguanine-DNA alkyltransferase activity with protracted temozolomide schedules in BRITISH JOURNAL OF CANCER
  • 2006-10. Discovery and development of sorafenib: a multikinase inhibitor for treating cancer in NATURE REVIEWS DRUG DISCOVERY
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1007/s11060-010-0217-6

    DOI

    http://dx.doi.org/10.1007/s11060-010-0217-6

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1048372978

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/20443129


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Oncology and Carcinogenesis", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Adult", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Aged", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Anticonvulsants", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Antineoplastic Combined Chemotherapy Protocols", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Benzenesulfonates", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Brain Neoplasms", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Cytochrome P-450 CYP3A", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Dacarbazine", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Disease-Free Survival", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Female", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Glioblastoma", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Humans", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Kaplan-Meier Estimate", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Male", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Middle Aged", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Neoplasm Recurrence, Local", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Niacinamide", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Phenylurea Compounds", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Pyridines", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Recurrence", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Sorafenib", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Temozolomide", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "Duke University Hospital", 
              "id": "https://www.grid.ac/institutes/grid.189509.c", 
              "name": [
                "Department of Surgery, Duke University Medical Center, 27710, Durham, NC, USA", 
                "Department of Pediatrics, Duke University Medical Center, 27710, Durham, NC, USA", 
                "The Brain Tumor Center at Duke, Duke University Medical Center, Box 3624, 27710, Durham, NC, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Reardon", 
            "givenName": "David A.", 
            "id": "sg:person.01334047606.77", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01334047606.77"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Duke Medical Center", 
              "id": "https://www.grid.ac/institutes/grid.414179.e", 
              "name": [
                "Department of Medicine, Duke University Medical Center, 27710, Durham, NC, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Vredenburgh", 
            "givenName": "James J.", 
            "id": "sg:person.013241345417.00", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013241345417.00"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Duke University Hospital", 
              "id": "https://www.grid.ac/institutes/grid.189509.c", 
              "name": [
                "Department of Neurology, Duke University Medical Center, 27710, Durham, NC, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Desjardins", 
            "givenName": "Annick", 
            "id": "sg:person.0701277507.35", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0701277507.35"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Duke University Hospital", 
              "id": "https://www.grid.ac/institutes/grid.189509.c", 
              "name": [
                "Department of Neurology, Duke University Medical Center, 27710, Durham, NC, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Peters", 
            "givenName": "Katherine", 
            "id": "sg:person.0744714665.06", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0744714665.06"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Duke University Hospital", 
              "id": "https://www.grid.ac/institutes/grid.189509.c", 
              "name": [
                "Department of Surgery, Duke University Medical Center, 27710, Durham, NC, USA", 
                "Department of Pediatrics, Duke University Medical Center, 27710, Durham, NC, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Gururangan", 
            "givenName": "Sridharan", 
            "id": "sg:person.010643343507.68", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010643343507.68"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Duke University Hospital", 
              "id": "https://www.grid.ac/institutes/grid.189509.c", 
              "name": [
                "Department of Surgery, Duke University Medical Center, 27710, Durham, NC, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Sampson", 
            "givenName": "John H.", 
            "id": "sg:person.01127256465.77", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01127256465.77"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Duke University Hospital", 
              "id": "https://www.grid.ac/institutes/grid.189509.c", 
              "name": [
                "Department of Cancer Center Biostatistics, Duke University Medical Center, 27710, Durham, NC, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Marcello", 
            "givenName": "Jennifer", 
            "id": "sg:person.01337202005.08", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01337202005.08"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Duke University Hospital", 
              "id": "https://www.grid.ac/institutes/grid.189509.c", 
              "name": [
                "Department of Cancer Center Biostatistics, Duke University Medical Center, 27710, Durham, NC, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Herndon", 
            "givenName": "James E.", 
            "id": "sg:person.01175371665.07", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01175371665.07"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Duke University Hospital", 
              "id": "https://www.grid.ac/institutes/grid.189509.c", 
              "name": [
                "Department of Pathology, Duke University Medical Center, 27710, Durham, NC, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "McLendon", 
            "givenName": "Roger E.", 
            "id": "sg:person.016522551017.09", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016522551017.09"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Duke University Hospital", 
              "id": "https://www.grid.ac/institutes/grid.189509.c", 
              "name": [
                "Department of Surgery, Duke University Medical Center, 27710, Durham, NC, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Janney", 
            "givenName": "Dorothea", 
            "id": "sg:person.01265231555.13", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01265231555.13"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Duke University Hospital", 
              "id": "https://www.grid.ac/institutes/grid.189509.c", 
              "name": [
                "Department of Surgery, Duke University Medical Center, 27710, Durham, NC, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Friedman", 
            "givenName": "Allan H.", 
            "id": "sg:person.01167656444.57", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01167656444.57"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Duke University Hospital", 
              "id": "https://www.grid.ac/institutes/grid.189509.c", 
              "name": [
                "Department of Pathology, Duke University Medical Center, 27710, Durham, NC, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Bigner", 
            "givenName": "Darell D.", 
            "id": "sg:person.013515206217.45", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013515206217.45"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Duke University Hospital", 
              "id": "https://www.grid.ac/institutes/grid.189509.c", 
              "name": [
                "Department of Surgery, Duke University Medical Center, 27710, Durham, NC, USA", 
                "Department of Pediatrics, Duke University Medical Center, 27710, Durham, NC, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Friedman", 
            "givenName": "Henry S.", 
            "id": "sg:person.01333344755.48", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01333344755.48"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "https://doi.org/10.1016/j.ccr.2006.11.021", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1000989893"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1200/jco.2009.26.5520", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1001482068"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1002/cncr.23167", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1002720754"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1158/1078-0432.ccr-06-2309", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1004441322"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1158/0008-5472.can-03-3831", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1006484288"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.3816/ccc.2005.n.030", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1007525216"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1200/jco.2005.03.2185", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1008334215"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1200/jco.2007.12.2440", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1008387745"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s11060-008-9749-4", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1008577769", 
              "https://doi.org/10.1007/s11060-008-9749-4"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1215/s1522851705000451", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1009504966"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1200/jco.2008.16.3055", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1010751135"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s11060-009-9980-7", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1010820167", 
              "https://doi.org/10.1007/s11060-009-9980-7"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s11060-009-9980-7", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1010820167", 
              "https://doi.org/10.1007/s11060-009-9980-7"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1080/07357900701708393", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1010997630"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00280-005-0068-6", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1011211358", 
              "https://doi.org/10.1007/s00280-005-0068-6"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00280-005-0068-6", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1011211358", 
              "https://doi.org/10.1007/s00280-005-0068-6"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1215/15228517-2009-006", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1011570339"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1023/b:neon.0000040837.68411.97", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1013936890", 
              "https://doi.org/10.1023/b:neon.0000040837.68411.97"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1158/1078-0432.ccr-09-2074", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1017392151"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1215/15228517-2008-078", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1020422065"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1158/1078-0432.ccr-05-1571", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1021236158"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1002/path.1823", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1023508516"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1002/path.1823", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1023508516"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nature00766", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1023536940", 
              "https://doi.org/10.1038/nature00766"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nature00766", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1023536940", 
              "https://doi.org/10.1038/nature00766"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.bjc.6603376", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1024206331", 
              "https://doi.org/10.1038/sj.bjc.6603376"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.bjc.6603376", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1024206331", 
              "https://doi.org/10.1038/sj.bjc.6603376"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1056/nejmoa060655", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1025111240"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1093/annonc/mdi310", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1028006302"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1093/annonc/mdi310", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1028006302"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1002/cncr.23813", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1028477771"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.bjc.6602584", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1028625172", 
              "https://doi.org/10.1038/sj.bjc.6602584"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.bjc.6602584", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1028625172", 
              "https://doi.org/10.1038/sj.bjc.6602584"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.bjc.6605225", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1030833831", 
              "https://doi.org/10.1038/sj.bjc.6605225"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1093/neuonc/4.1.39", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1031027325"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1200/jco.2007.15.7636", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1034168619"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.bjc.6600827", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1035507002", 
              "https://doi.org/10.1038/sj.bjc.6600827"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.bjc.6600827", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1035507002", 
              "https://doi.org/10.1038/sj.bjc.6600827"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1158/1078-0432.ccr-06-0773", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1036384516"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.2165/00003495-200969020-00006", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1037157538", 
              "https://doi.org/10.2165/00003495-200969020-00006"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nrd2130", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1038997035", 
              "https://doi.org/10.1038/nrd2130"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nrd2130", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1038997035", 
              "https://doi.org/10.1038/nrd2130"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1200/jco.2008.16.9235", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1039289078"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1158/1078-0432.ccr-04-2658", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1040669587"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1158/1078-0432.ccr-05-2202", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1041834215"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1200/jco.2008.19.8721", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1042965400"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1158/1541-7786.mcr-06-0085", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1043369568"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1200/jco.2007.10.7722", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1045405526"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1215/15228517-2007-062", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1046098276"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1158/1535-7163.mct-08-0013", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1048133345"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1158/1078-0432.ccr-08-0260", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1048254167"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1158/1078-0432.ccr-08-2280", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1049158540"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/s0305-7372(97)90019-0", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1049471028"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1056/nejmoa0708857", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1053513212"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1021/bi00197a003", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1055164786"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1212/01.wnl.0000196465.83423.ec", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1064347796"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1212/01.wnl.0000196465.83423.ec", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1064347796"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1212/01.wnl.0000196465.83423.ec", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1064347796"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1212/01.wnl.0000304121.57857.38", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1064350042"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1212/01.wnl.0000304121.57857.38", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1064350042"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1212/01.wnl.0000304121.57857.38", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1064350042"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1215/15228517-2006-025", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1064414261"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1215/15228517-4-1-39", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1064414464"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1215/s1152851703000292", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1064420609"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.3892/or.16.5.1117", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1071530200"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.5414/cpp42650", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1072835160"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1200/jco.1999.17.8.2572", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1074549881"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1200/jco.1999.17.9.2762", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1074549908"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://app.dimensions.ai/details/publication/pub.1075330701", 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://app.dimensions.ai/details/publication/pub.1075516477", 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1200/jco.1990.8.7.1277", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1078716995"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://app.dimensions.ai/details/publication/pub.1083327368", 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "2011-01", 
        "datePublishedReg": "2011-01-01", 
        "description": "Sorafenib, an oral VEGFR-2, Raf, PDGFR, c-KIT and Flt-3 inhibitor, is active against renal cell and hepatocellular carcinomas, and has recently demonstrated promising activity for lung and breast cancers. In addition, various protracted temozolomide dosing schedules have been evaluated as a strategy to further enhance its anti-tumor activity. We reasoned that sorafenib and protracted, daily temozolomide may provide complementary therapeutic benefit, and therefore performed a phase 2 trial among recurrent glioblastoma patients. Adult glioblastoma patients at any recurrence after standard temozolomide chemoradiotherapy received sorafenib (400 mg twice daily) and continuous daily temozolomide (50 mg/m\u00b2/day). Assessments were performed every eight weeks. The primary endpoint was progression-free survival at 6 months (PFS-6) and secondary end points were radiographic response, overall survival (OS), safety and sorafenib pharmacokinetics. Of 32 enrolled patients, 12 (38%) were on CYP3-A inducing anti-epileptics (EIAEDs), 17 (53%) had 2 or more prior progressions, 15 had progressed while receiving 5-day temozolomide, and 12 (38%) had failed either prior bevacizumab or VEGFR inhibitor therapy. The most common grade \u2265 3 toxicities were palmer-planter erythrodysesthesia (19%) and elevated amylase/lipase (13%). Sorafenib pharmacokinetic exposures were comparable on day 1 regardless of EIAED status, but significantly lower on day 28 for patients on EIAEDs (P = 0.0431). With a median follow-up of 93 weeks, PFS-6 was 9.4%. Only one patient (3%) achieved a partial response. In conclusion, sorafenib can be safely administered with daily temozolomide, but this regimen has limited activity for recurrent GBM. Co-administration of EIAEDs can lower sorafenib exposures in this population.", 
        "genre": "research_article", 
        "id": "sg:pub.10.1007/s11060-010-0217-6", 
        "inLanguage": [
          "en"
        ], 
        "isAccessibleForFree": true, 
        "isFundedItemOf": [
          {
            "id": "sg:grant.2441054", 
            "type": "MonetaryGrant"
          }, 
          {
            "id": "sg:grant.2465896", 
            "type": "MonetaryGrant"
          }, 
          {
            "id": "sg:grant.2681733", 
            "type": "MonetaryGrant"
          }, 
          {
            "id": "sg:grant.2437681", 
            "type": "MonetaryGrant"
          }, 
          {
            "id": "sg:grant.2634129", 
            "type": "MonetaryGrant"
          }
        ], 
        "isPartOf": [
          {
            "id": "sg:journal.1094205", 
            "issn": [
              "0167-594X", 
              "1573-7373"
            ], 
            "name": "Journal of Neuro-Oncology", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "1", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "101"
          }
        ], 
        "name": "Effect of CYP3A-inducing anti-epileptics on sorafenib exposure: results of a phase II study of sorafenib plus daily temozolomide in adults with recurrent glioblastoma", 
        "pagination": "57-66", 
        "productId": [
          {
            "name": "readcube_id", 
            "type": "PropertyValue", 
            "value": [
              "e670b5575153ec6187175587932bf93f7472a307c032265ea226366649bc34cf"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "20443129"
            ]
          }, 
          {
            "name": "nlm_unique_id", 
            "type": "PropertyValue", 
            "value": [
              "8309335"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1007/s11060-010-0217-6"
            ]
          }, 
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1048372978"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1007/s11060-010-0217-6", 
          "https://app.dimensions.ai/details/publication/pub.1048372978"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2019-04-11T10:28", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000349_0000000349/records_113640_00000002.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "http://link.springer.com/10.1007%2Fs11060-010-0217-6"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s11060-010-0217-6'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s11060-010-0217-6'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s11060-010-0217-6'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s11060-010-0217-6'


     

    This table displays all metadata directly associated to this object as RDF triples.

    444 TRIPLES      21 PREDICATES      110 URIs      43 LITERALS      31 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1007/s11060-010-0217-6 schema:about N2012d91a9d594acd87885f57299f3cba
    2 N29fb996b55884addbb36a614c1bff620
    3 N2f92e041f46a43809842960c910fbe9c
    4 N3305d87a8a2544f1af7d93ade7a07589
    5 N3cfce9cf4ba04890b29d1a30c9470a45
    6 N3d170a46d6524eb4a96282d207d2a3df
    7 N53cb84317d394843a62ee0a8af680a2f
    8 N5bb4d649b99f455ea4a1ef14bf0656b2
    9 N616ed97607264ea785ce751de2d6a5c8
    10 N63170e4c0e174d1897e6b9e71d84188a
    11 N6b3a6d4ab7dd46709717311c69199c3b
    12 N865f85c98660460e97b2d9ec216773f8
    13 N9650c07a47854776bfc01938737876d8
    14 N9ee2a576d0ea4f1689ed9ffaa8e592a4
    15 Nb0cf2cbbbf834ad8bdc83963d7921216
    16 Nb113d0ebe6204eedab57b751e16ce77e
    17 Nbe80617701324ccab0e7004c06f53756
    18 Nd56d4540a221425fa9695237fb394c70
    19 Nddb3c7623b9149aea7645c0524970a7b
    20 Ne683b4a0d7b546b9933bd6e34d9228be
    21 Nf239169d6f8541a19036857b00f55dc2
    22 Nfcf6ac20059f4428b69ad226b337fdb9
    23 anzsrc-for:11
    24 anzsrc-for:1112
    25 schema:author Ncd071a852bf54053b42fc3fdff9e9843
    26 schema:citation sg:pub.10.1007/s00280-005-0068-6
    27 sg:pub.10.1007/s11060-008-9749-4
    28 sg:pub.10.1007/s11060-009-9980-7
    29 sg:pub.10.1023/b:neon.0000040837.68411.97
    30 sg:pub.10.1038/nature00766
    31 sg:pub.10.1038/nrd2130
    32 sg:pub.10.1038/sj.bjc.6600827
    33 sg:pub.10.1038/sj.bjc.6602584
    34 sg:pub.10.1038/sj.bjc.6603376
    35 sg:pub.10.1038/sj.bjc.6605225
    36 sg:pub.10.2165/00003495-200969020-00006
    37 https://app.dimensions.ai/details/publication/pub.1075330701
    38 https://app.dimensions.ai/details/publication/pub.1075516477
    39 https://app.dimensions.ai/details/publication/pub.1083327368
    40 https://doi.org/10.1002/cncr.23167
    41 https://doi.org/10.1002/cncr.23813
    42 https://doi.org/10.1002/path.1823
    43 https://doi.org/10.1016/j.ccr.2006.11.021
    44 https://doi.org/10.1016/s0305-7372(97)90019-0
    45 https://doi.org/10.1021/bi00197a003
    46 https://doi.org/10.1056/nejmoa060655
    47 https://doi.org/10.1056/nejmoa0708857
    48 https://doi.org/10.1080/07357900701708393
    49 https://doi.org/10.1093/annonc/mdi310
    50 https://doi.org/10.1093/neuonc/4.1.39
    51 https://doi.org/10.1158/0008-5472.can-03-3831
    52 https://doi.org/10.1158/1078-0432.ccr-04-2658
    53 https://doi.org/10.1158/1078-0432.ccr-05-1571
    54 https://doi.org/10.1158/1078-0432.ccr-05-2202
    55 https://doi.org/10.1158/1078-0432.ccr-06-0773
    56 https://doi.org/10.1158/1078-0432.ccr-06-2309
    57 https://doi.org/10.1158/1078-0432.ccr-08-0260
    58 https://doi.org/10.1158/1078-0432.ccr-08-2280
    59 https://doi.org/10.1158/1078-0432.ccr-09-2074
    60 https://doi.org/10.1158/1535-7163.mct-08-0013
    61 https://doi.org/10.1158/1541-7786.mcr-06-0085
    62 https://doi.org/10.1200/jco.1990.8.7.1277
    63 https://doi.org/10.1200/jco.1999.17.8.2572
    64 https://doi.org/10.1200/jco.1999.17.9.2762
    65 https://doi.org/10.1200/jco.2005.03.2185
    66 https://doi.org/10.1200/jco.2007.10.7722
    67 https://doi.org/10.1200/jco.2007.12.2440
    68 https://doi.org/10.1200/jco.2007.15.7636
    69 https://doi.org/10.1200/jco.2008.16.3055
    70 https://doi.org/10.1200/jco.2008.16.9235
    71 https://doi.org/10.1200/jco.2008.19.8721
    72 https://doi.org/10.1200/jco.2009.26.5520
    73 https://doi.org/10.1212/01.wnl.0000196465.83423.ec
    74 https://doi.org/10.1212/01.wnl.0000304121.57857.38
    75 https://doi.org/10.1215/15228517-2006-025
    76 https://doi.org/10.1215/15228517-2007-062
    77 https://doi.org/10.1215/15228517-2008-078
    78 https://doi.org/10.1215/15228517-2009-006
    79 https://doi.org/10.1215/15228517-4-1-39
    80 https://doi.org/10.1215/s1152851703000292
    81 https://doi.org/10.1215/s1522851705000451
    82 https://doi.org/10.3816/ccc.2005.n.030
    83 https://doi.org/10.3892/or.16.5.1117
    84 https://doi.org/10.5414/cpp42650
    85 schema:datePublished 2011-01
    86 schema:datePublishedReg 2011-01-01
    87 schema:description Sorafenib, an oral VEGFR-2, Raf, PDGFR, c-KIT and Flt-3 inhibitor, is active against renal cell and hepatocellular carcinomas, and has recently demonstrated promising activity for lung and breast cancers. In addition, various protracted temozolomide dosing schedules have been evaluated as a strategy to further enhance its anti-tumor activity. We reasoned that sorafenib and protracted, daily temozolomide may provide complementary therapeutic benefit, and therefore performed a phase 2 trial among recurrent glioblastoma patients. Adult glioblastoma patients at any recurrence after standard temozolomide chemoradiotherapy received sorafenib (400 mg twice daily) and continuous daily temozolomide (50 mg/m²/day). Assessments were performed every eight weeks. The primary endpoint was progression-free survival at 6 months (PFS-6) and secondary end points were radiographic response, overall survival (OS), safety and sorafenib pharmacokinetics. Of 32 enrolled patients, 12 (38%) were on CYP3-A inducing anti-epileptics (EIAEDs), 17 (53%) had 2 or more prior progressions, 15 had progressed while receiving 5-day temozolomide, and 12 (38%) had failed either prior bevacizumab or VEGFR inhibitor therapy. The most common grade ≥ 3 toxicities were palmer-planter erythrodysesthesia (19%) and elevated amylase/lipase (13%). Sorafenib pharmacokinetic exposures were comparable on day 1 regardless of EIAED status, but significantly lower on day 28 for patients on EIAEDs (P = 0.0431). With a median follow-up of 93 weeks, PFS-6 was 9.4%. Only one patient (3%) achieved a partial response. In conclusion, sorafenib can be safely administered with daily temozolomide, but this regimen has limited activity for recurrent GBM. Co-administration of EIAEDs can lower sorafenib exposures in this population.
    88 schema:genre research_article
    89 schema:inLanguage en
    90 schema:isAccessibleForFree true
    91 schema:isPartOf N63aeb5516d0e434d9576cbd3d62a2393
    92 N6b2dc442651e49a6bdce6bf2a06e3c98
    93 sg:journal.1094205
    94 schema:name Effect of CYP3A-inducing anti-epileptics on sorafenib exposure: results of a phase II study of sorafenib plus daily temozolomide in adults with recurrent glioblastoma
    95 schema:pagination 57-66
    96 schema:productId N0b35e1fd00654f259f29e844985d3173
    97 N6cb7f696566643f28b19cf6b7c3a1a65
    98 N769603fbcb884bb5af187d6215ae618e
    99 Nb0ada4e78c414758b306420d029b512c
    100 Ne2b9f9579c9b440faa8542eaffaa9e3d
    101 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048372978
    102 https://doi.org/10.1007/s11060-010-0217-6
    103 schema:sdDatePublished 2019-04-11T10:28
    104 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    105 schema:sdPublisher N4782b114f3314ee19fd358903419ec3a
    106 schema:url http://link.springer.com/10.1007%2Fs11060-010-0217-6
    107 sgo:license sg:explorer/license/
    108 sgo:sdDataset articles
    109 rdf:type schema:ScholarlyArticle
    110 N0b082c6bb68442019e0c2b7e77a23985 rdf:first sg:person.013515206217.45
    111 rdf:rest Nc90b2cddcefb47d2bd95610b938c31bb
    112 N0b35e1fd00654f259f29e844985d3173 schema:name doi
    113 schema:value 10.1007/s11060-010-0217-6
    114 rdf:type schema:PropertyValue
    115 N2012d91a9d594acd87885f57299f3cba schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    116 schema:name Temozolomide
    117 rdf:type schema:DefinedTerm
    118 N29fb996b55884addbb36a614c1bff620 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    119 schema:name Sorafenib
    120 rdf:type schema:DefinedTerm
    121 N2f92e041f46a43809842960c910fbe9c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    122 schema:name Disease-Free Survival
    123 rdf:type schema:DefinedTerm
    124 N3305d87a8a2544f1af7d93ade7a07589 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    125 schema:name Middle Aged
    126 rdf:type schema:DefinedTerm
    127 N3cfce9cf4ba04890b29d1a30c9470a45 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    128 schema:name Dacarbazine
    129 rdf:type schema:DefinedTerm
    130 N3d170a46d6524eb4a96282d207d2a3df schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    131 schema:name Cytochrome P-450 CYP3A
    132 rdf:type schema:DefinedTerm
    133 N4106761d42634600bb0787d99a887b46 rdf:first sg:person.01175371665.07
    134 rdf:rest Nd19004e5aaed4834a4f1bf8a288504f9
    135 N4782b114f3314ee19fd358903419ec3a schema:name Springer Nature - SN SciGraph project
    136 rdf:type schema:Organization
    137 N53cb84317d394843a62ee0a8af680a2f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    138 schema:name Neoplasm Recurrence, Local
    139 rdf:type schema:DefinedTerm
    140 N5bb4d649b99f455ea4a1ef14bf0656b2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    141 schema:name Anticonvulsants
    142 rdf:type schema:DefinedTerm
    143 N616ed97607264ea785ce751de2d6a5c8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    144 schema:name Adult
    145 rdf:type schema:DefinedTerm
    146 N63170e4c0e174d1897e6b9e71d84188a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    147 schema:name Male
    148 rdf:type schema:DefinedTerm
    149 N63aeb5516d0e434d9576cbd3d62a2393 schema:issueNumber 1
    150 rdf:type schema:PublicationIssue
    151 N6b2dc442651e49a6bdce6bf2a06e3c98 schema:volumeNumber 101
    152 rdf:type schema:PublicationVolume
    153 N6b3a6d4ab7dd46709717311c69199c3b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    154 schema:name Antineoplastic Combined Chemotherapy Protocols
    155 rdf:type schema:DefinedTerm
    156 N6cb7f696566643f28b19cf6b7c3a1a65 schema:name readcube_id
    157 schema:value e670b5575153ec6187175587932bf93f7472a307c032265ea226366649bc34cf
    158 rdf:type schema:PropertyValue
    159 N769603fbcb884bb5af187d6215ae618e schema:name dimensions_id
    160 schema:value pub.1048372978
    161 rdf:type schema:PropertyValue
    162 N865f85c98660460e97b2d9ec216773f8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    163 schema:name Aged
    164 rdf:type schema:DefinedTerm
    165 N8b4fd51bb707458dae0083d6c4bbc381 rdf:first sg:person.01167656444.57
    166 rdf:rest N0b082c6bb68442019e0c2b7e77a23985
    167 N90ec9339a59f4338b6870140bf8c3109 rdf:first sg:person.01265231555.13
    168 rdf:rest N8b4fd51bb707458dae0083d6c4bbc381
    169 N93813410d4924f57ab511c42232da93f rdf:first sg:person.0701277507.35
    170 rdf:rest Nee681a960efc419d9939b192586c4059
    171 N9650c07a47854776bfc01938737876d8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    172 schema:name Brain Neoplasms
    173 rdf:type schema:DefinedTerm
    174 N9ee2a576d0ea4f1689ed9ffaa8e592a4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    175 schema:name Pyridines
    176 rdf:type schema:DefinedTerm
    177 N9f94ada989e54cd48a45a351e5d4604e rdf:first sg:person.013241345417.00
    178 rdf:rest N93813410d4924f57ab511c42232da93f
    179 Nabd67183765949548a664ead49ef65aa rdf:first sg:person.01127256465.77
    180 rdf:rest Nd9f6661fdd0845afb827c87cdc6530f7
    181 Nb0ada4e78c414758b306420d029b512c schema:name nlm_unique_id
    182 schema:value 8309335
    183 rdf:type schema:PropertyValue
    184 Nb0cf2cbbbf834ad8bdc83963d7921216 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    185 schema:name Niacinamide
    186 rdf:type schema:DefinedTerm
    187 Nb113d0ebe6204eedab57b751e16ce77e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    188 schema:name Benzenesulfonates
    189 rdf:type schema:DefinedTerm
    190 Nb2d9f8d008af41a88d77c507cc4b20ff rdf:first sg:person.010643343507.68
    191 rdf:rest Nabd67183765949548a664ead49ef65aa
    192 Nbe80617701324ccab0e7004c06f53756 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    193 schema:name Kaplan-Meier Estimate
    194 rdf:type schema:DefinedTerm
    195 Nc90b2cddcefb47d2bd95610b938c31bb rdf:first sg:person.01333344755.48
    196 rdf:rest rdf:nil
    197 Ncd071a852bf54053b42fc3fdff9e9843 rdf:first sg:person.01334047606.77
    198 rdf:rest N9f94ada989e54cd48a45a351e5d4604e
    199 Nd19004e5aaed4834a4f1bf8a288504f9 rdf:first sg:person.016522551017.09
    200 rdf:rest N90ec9339a59f4338b6870140bf8c3109
    201 Nd56d4540a221425fa9695237fb394c70 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    202 schema:name Glioblastoma
    203 rdf:type schema:DefinedTerm
    204 Nd9f6661fdd0845afb827c87cdc6530f7 rdf:first sg:person.01337202005.08
    205 rdf:rest N4106761d42634600bb0787d99a887b46
    206 Nddb3c7623b9149aea7645c0524970a7b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    207 schema:name Recurrence
    208 rdf:type schema:DefinedTerm
    209 Ne2b9f9579c9b440faa8542eaffaa9e3d schema:name pubmed_id
    210 schema:value 20443129
    211 rdf:type schema:PropertyValue
    212 Ne683b4a0d7b546b9933bd6e34d9228be schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    213 schema:name Humans
    214 rdf:type schema:DefinedTerm
    215 Nee681a960efc419d9939b192586c4059 rdf:first sg:person.0744714665.06
    216 rdf:rest Nb2d9f8d008af41a88d77c507cc4b20ff
    217 Nf239169d6f8541a19036857b00f55dc2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    218 schema:name Female
    219 rdf:type schema:DefinedTerm
    220 Nfcf6ac20059f4428b69ad226b337fdb9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    221 schema:name Phenylurea Compounds
    222 rdf:type schema:DefinedTerm
    223 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    224 schema:name Medical and Health Sciences
    225 rdf:type schema:DefinedTerm
    226 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
    227 schema:name Oncology and Carcinogenesis
    228 rdf:type schema:DefinedTerm
    229 sg:grant.2437681 http://pending.schema.org/fundedItem sg:pub.10.1007/s11060-010-0217-6
    230 rdf:type schema:MonetaryGrant
    231 sg:grant.2441054 http://pending.schema.org/fundedItem sg:pub.10.1007/s11060-010-0217-6
    232 rdf:type schema:MonetaryGrant
    233 sg:grant.2465896 http://pending.schema.org/fundedItem sg:pub.10.1007/s11060-010-0217-6
    234 rdf:type schema:MonetaryGrant
    235 sg:grant.2634129 http://pending.schema.org/fundedItem sg:pub.10.1007/s11060-010-0217-6
    236 rdf:type schema:MonetaryGrant
    237 sg:grant.2681733 http://pending.schema.org/fundedItem sg:pub.10.1007/s11060-010-0217-6
    238 rdf:type schema:MonetaryGrant
    239 sg:journal.1094205 schema:issn 0167-594X
    240 1573-7373
    241 schema:name Journal of Neuro-Oncology
    242 rdf:type schema:Periodical
    243 sg:person.010643343507.68 schema:affiliation https://www.grid.ac/institutes/grid.189509.c
    244 schema:familyName Gururangan
    245 schema:givenName Sridharan
    246 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010643343507.68
    247 rdf:type schema:Person
    248 sg:person.01127256465.77 schema:affiliation https://www.grid.ac/institutes/grid.189509.c
    249 schema:familyName Sampson
    250 schema:givenName John H.
    251 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01127256465.77
    252 rdf:type schema:Person
    253 sg:person.01167656444.57 schema:affiliation https://www.grid.ac/institutes/grid.189509.c
    254 schema:familyName Friedman
    255 schema:givenName Allan H.
    256 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01167656444.57
    257 rdf:type schema:Person
    258 sg:person.01175371665.07 schema:affiliation https://www.grid.ac/institutes/grid.189509.c
    259 schema:familyName Herndon
    260 schema:givenName James E.
    261 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01175371665.07
    262 rdf:type schema:Person
    263 sg:person.01265231555.13 schema:affiliation https://www.grid.ac/institutes/grid.189509.c
    264 schema:familyName Janney
    265 schema:givenName Dorothea
    266 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01265231555.13
    267 rdf:type schema:Person
    268 sg:person.013241345417.00 schema:affiliation https://www.grid.ac/institutes/grid.414179.e
    269 schema:familyName Vredenburgh
    270 schema:givenName James J.
    271 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013241345417.00
    272 rdf:type schema:Person
    273 sg:person.01333344755.48 schema:affiliation https://www.grid.ac/institutes/grid.189509.c
    274 schema:familyName Friedman
    275 schema:givenName Henry S.
    276 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01333344755.48
    277 rdf:type schema:Person
    278 sg:person.01334047606.77 schema:affiliation https://www.grid.ac/institutes/grid.189509.c
    279 schema:familyName Reardon
    280 schema:givenName David A.
    281 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01334047606.77
    282 rdf:type schema:Person
    283 sg:person.01337202005.08 schema:affiliation https://www.grid.ac/institutes/grid.189509.c
    284 schema:familyName Marcello
    285 schema:givenName Jennifer
    286 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01337202005.08
    287 rdf:type schema:Person
    288 sg:person.013515206217.45 schema:affiliation https://www.grid.ac/institutes/grid.189509.c
    289 schema:familyName Bigner
    290 schema:givenName Darell D.
    291 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013515206217.45
    292 rdf:type schema:Person
    293 sg:person.016522551017.09 schema:affiliation https://www.grid.ac/institutes/grid.189509.c
    294 schema:familyName McLendon
    295 schema:givenName Roger E.
    296 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016522551017.09
    297 rdf:type schema:Person
    298 sg:person.0701277507.35 schema:affiliation https://www.grid.ac/institutes/grid.189509.c
    299 schema:familyName Desjardins
    300 schema:givenName Annick
    301 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0701277507.35
    302 rdf:type schema:Person
    303 sg:person.0744714665.06 schema:affiliation https://www.grid.ac/institutes/grid.189509.c
    304 schema:familyName Peters
    305 schema:givenName Katherine
    306 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0744714665.06
    307 rdf:type schema:Person
    308 sg:pub.10.1007/s00280-005-0068-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011211358
    309 https://doi.org/10.1007/s00280-005-0068-6
    310 rdf:type schema:CreativeWork
    311 sg:pub.10.1007/s11060-008-9749-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008577769
    312 https://doi.org/10.1007/s11060-008-9749-4
    313 rdf:type schema:CreativeWork
    314 sg:pub.10.1007/s11060-009-9980-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010820167
    315 https://doi.org/10.1007/s11060-009-9980-7
    316 rdf:type schema:CreativeWork
    317 sg:pub.10.1023/b:neon.0000040837.68411.97 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013936890
    318 https://doi.org/10.1023/b:neon.0000040837.68411.97
    319 rdf:type schema:CreativeWork
    320 sg:pub.10.1038/nature00766 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023536940
    321 https://doi.org/10.1038/nature00766
    322 rdf:type schema:CreativeWork
    323 sg:pub.10.1038/nrd2130 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038997035
    324 https://doi.org/10.1038/nrd2130
    325 rdf:type schema:CreativeWork
    326 sg:pub.10.1038/sj.bjc.6600827 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035507002
    327 https://doi.org/10.1038/sj.bjc.6600827
    328 rdf:type schema:CreativeWork
    329 sg:pub.10.1038/sj.bjc.6602584 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028625172
    330 https://doi.org/10.1038/sj.bjc.6602584
    331 rdf:type schema:CreativeWork
    332 sg:pub.10.1038/sj.bjc.6603376 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024206331
    333 https://doi.org/10.1038/sj.bjc.6603376
    334 rdf:type schema:CreativeWork
    335 sg:pub.10.1038/sj.bjc.6605225 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030833831
    336 https://doi.org/10.1038/sj.bjc.6605225
    337 rdf:type schema:CreativeWork
    338 sg:pub.10.2165/00003495-200969020-00006 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037157538
    339 https://doi.org/10.2165/00003495-200969020-00006
    340 rdf:type schema:CreativeWork
    341 https://app.dimensions.ai/details/publication/pub.1075330701 schema:CreativeWork
    342 https://app.dimensions.ai/details/publication/pub.1075516477 schema:CreativeWork
    343 https://app.dimensions.ai/details/publication/pub.1083327368 schema:CreativeWork
    344 https://doi.org/10.1002/cncr.23167 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002720754
    345 rdf:type schema:CreativeWork
    346 https://doi.org/10.1002/cncr.23813 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028477771
    347 rdf:type schema:CreativeWork
    348 https://doi.org/10.1002/path.1823 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023508516
    349 rdf:type schema:CreativeWork
    350 https://doi.org/10.1016/j.ccr.2006.11.021 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000989893
    351 rdf:type schema:CreativeWork
    352 https://doi.org/10.1016/s0305-7372(97)90019-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049471028
    353 rdf:type schema:CreativeWork
    354 https://doi.org/10.1021/bi00197a003 schema:sameAs https://app.dimensions.ai/details/publication/pub.1055164786
    355 rdf:type schema:CreativeWork
    356 https://doi.org/10.1056/nejmoa060655 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025111240
    357 rdf:type schema:CreativeWork
    358 https://doi.org/10.1056/nejmoa0708857 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053513212
    359 rdf:type schema:CreativeWork
    360 https://doi.org/10.1080/07357900701708393 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010997630
    361 rdf:type schema:CreativeWork
    362 https://doi.org/10.1093/annonc/mdi310 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028006302
    363 rdf:type schema:CreativeWork
    364 https://doi.org/10.1093/neuonc/4.1.39 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031027325
    365 rdf:type schema:CreativeWork
    366 https://doi.org/10.1158/0008-5472.can-03-3831 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006484288
    367 rdf:type schema:CreativeWork
    368 https://doi.org/10.1158/1078-0432.ccr-04-2658 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040669587
    369 rdf:type schema:CreativeWork
    370 https://doi.org/10.1158/1078-0432.ccr-05-1571 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021236158
    371 rdf:type schema:CreativeWork
    372 https://doi.org/10.1158/1078-0432.ccr-05-2202 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041834215
    373 rdf:type schema:CreativeWork
    374 https://doi.org/10.1158/1078-0432.ccr-06-0773 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036384516
    375 rdf:type schema:CreativeWork
    376 https://doi.org/10.1158/1078-0432.ccr-06-2309 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004441322
    377 rdf:type schema:CreativeWork
    378 https://doi.org/10.1158/1078-0432.ccr-08-0260 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048254167
    379 rdf:type schema:CreativeWork
    380 https://doi.org/10.1158/1078-0432.ccr-08-2280 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049158540
    381 rdf:type schema:CreativeWork
    382 https://doi.org/10.1158/1078-0432.ccr-09-2074 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017392151
    383 rdf:type schema:CreativeWork
    384 https://doi.org/10.1158/1535-7163.mct-08-0013 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048133345
    385 rdf:type schema:CreativeWork
    386 https://doi.org/10.1158/1541-7786.mcr-06-0085 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043369568
    387 rdf:type schema:CreativeWork
    388 https://doi.org/10.1200/jco.1990.8.7.1277 schema:sameAs https://app.dimensions.ai/details/publication/pub.1078716995
    389 rdf:type schema:CreativeWork
    390 https://doi.org/10.1200/jco.1999.17.8.2572 schema:sameAs https://app.dimensions.ai/details/publication/pub.1074549881
    391 rdf:type schema:CreativeWork
    392 https://doi.org/10.1200/jco.1999.17.9.2762 schema:sameAs https://app.dimensions.ai/details/publication/pub.1074549908
    393 rdf:type schema:CreativeWork
    394 https://doi.org/10.1200/jco.2005.03.2185 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008334215
    395 rdf:type schema:CreativeWork
    396 https://doi.org/10.1200/jco.2007.10.7722 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045405526
    397 rdf:type schema:CreativeWork
    398 https://doi.org/10.1200/jco.2007.12.2440 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008387745
    399 rdf:type schema:CreativeWork
    400 https://doi.org/10.1200/jco.2007.15.7636 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034168619
    401 rdf:type schema:CreativeWork
    402 https://doi.org/10.1200/jco.2008.16.3055 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010751135
    403 rdf:type schema:CreativeWork
    404 https://doi.org/10.1200/jco.2008.16.9235 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039289078
    405 rdf:type schema:CreativeWork
    406 https://doi.org/10.1200/jco.2008.19.8721 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042965400
    407 rdf:type schema:CreativeWork
    408 https://doi.org/10.1200/jco.2009.26.5520 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001482068
    409 rdf:type schema:CreativeWork
    410 https://doi.org/10.1212/01.wnl.0000196465.83423.ec schema:sameAs https://app.dimensions.ai/details/publication/pub.1064347796
    411 rdf:type schema:CreativeWork
    412 https://doi.org/10.1212/01.wnl.0000304121.57857.38 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064350042
    413 rdf:type schema:CreativeWork
    414 https://doi.org/10.1215/15228517-2006-025 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064414261
    415 rdf:type schema:CreativeWork
    416 https://doi.org/10.1215/15228517-2007-062 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046098276
    417 rdf:type schema:CreativeWork
    418 https://doi.org/10.1215/15228517-2008-078 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020422065
    419 rdf:type schema:CreativeWork
    420 https://doi.org/10.1215/15228517-2009-006 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011570339
    421 rdf:type schema:CreativeWork
    422 https://doi.org/10.1215/15228517-4-1-39 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064414464
    423 rdf:type schema:CreativeWork
    424 https://doi.org/10.1215/s1152851703000292 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064420609
    425 rdf:type schema:CreativeWork
    426 https://doi.org/10.1215/s1522851705000451 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009504966
    427 rdf:type schema:CreativeWork
    428 https://doi.org/10.3816/ccc.2005.n.030 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007525216
    429 rdf:type schema:CreativeWork
    430 https://doi.org/10.3892/or.16.5.1117 schema:sameAs https://app.dimensions.ai/details/publication/pub.1071530200
    431 rdf:type schema:CreativeWork
    432 https://doi.org/10.5414/cpp42650 schema:sameAs https://app.dimensions.ai/details/publication/pub.1072835160
    433 rdf:type schema:CreativeWork
    434 https://www.grid.ac/institutes/grid.189509.c schema:alternateName Duke University Hospital
    435 schema:name Department of Cancer Center Biostatistics, Duke University Medical Center, 27710, Durham, NC, USA
    436 Department of Neurology, Duke University Medical Center, 27710, Durham, NC, USA
    437 Department of Pathology, Duke University Medical Center, 27710, Durham, NC, USA
    438 Department of Pediatrics, Duke University Medical Center, 27710, Durham, NC, USA
    439 Department of Surgery, Duke University Medical Center, 27710, Durham, NC, USA
    440 The Brain Tumor Center at Duke, Duke University Medical Center, Box 3624, 27710, Durham, NC, USA
    441 rdf:type schema:Organization
    442 https://www.grid.ac/institutes/grid.414179.e schema:alternateName Duke Medical Center
    443 schema:name Department of Medicine, Duke University Medical Center, 27710, Durham, NC, USA
    444 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...